Lumosa Therapeutics Market Cap

Lumosa Therapeutics has a market cap or net worth of 39.69 billion as of February 21, 2025. Its market cap has increased by 183.71% in one year.

Market Cap

39.69B

Enterprise Value

39.17B

Revenue

37.82M

Ranking

n/a

PE Ratio

n/a

Stock Price

235.00

Market Cap Chart

Since July 16, 2015, Lumosa Therapeutics's market cap has increased from 4.29B to 39.69B, an increase of 824.14%. That is a compound annual growth rate of 26.03%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	39.69B	-6.00%
Dec 31, 2024	42.22B	274.74%
Dec 29, 2023	11.27B	75.37%
Dec 30, 2022	6.43B	5.04%
Dec 30, 2021	6.12B	17.77%
Dec 31, 2020	5.19B	28.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	226.03B
Caliway Biopharmaceuticals	145.92B
Bora Pharmaceuticals Co., LTD.	90.53B
Lotus Pharmaceutical	72.59B
Oneness Biotech	38.77B
Polaris Group	36.53B
Pegavision	30.34B
Center Laboratories	29.39B

Market Cap Rankings